Free Trial

Adverum Biotechnologies (ADVM) Insider Trading & Ownership

Adverum Biotechnologies logo
$6.17 -0.08 (-1.28%)
(As of 11/20/2024 ET)

Adverum Biotechnologies (NASDAQ:ADVM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.20%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$1.80 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get ADVM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adverum Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ADVM Insider Buying and Selling by Quarter

Adverum Biotechnologies Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/30/2024Braden Michael LeonardMajor ShareholderBuy85,800$7.15$613,470.00  
7/17/2024Braden Michael LeonardMajor ShareholderBuy135,546$7.75$1,050,481.50  
2/7/2024James Paul ScopaDirectorBuy10,000$13.50$135,000.00  
(Data available from 1/1/2013 forward)

ADVM Insider Trading Activity - Frequently Asked Questions

The list of insiders at Adverum Biotechnologies includes Braden Michael Leonard, Brigit Riley, Dawn Svoronos, James Paul Scopa, Laurent Fischer, Peter Soparkar, Richard Beckman, Rupert D'souza, and Setareh Seyedkazemi. Learn more on insiders at ADVM.

4.20% of Adverum Biotechnologies stock is owned by insiders. Learn more on ADVM's insider holdings.

The following insiders have purchased ADVM shares in the last 24 months: Braden Michael Leonard ($1,663,951.50), and James Paul Scopa ($135,000.00).

Insiders have purchased a total of 231,346 ADVM shares in the last 24 months for a total of $1,798,951.50 bought.

The following insiders have sold ADVM shares in the last 24 months: Brigit Riley ($5,686.20), Laurent Fischer ($32,159.40), Peter Soparkar ($10,420.80), and Setareh Seyedkazemi ($9,424.00).

Insiders have sold a total of 6,808 Adverum Biotechnologies shares in the last 24 months for a total of $57,690.40 sold.

Adverum Biotechnologies Key Executives

  • Dr. Laurent FischerDr. Laurent Fischer (Age 60)
    President, CEO & Director
    Compensation: $1.02M
  • Ms. Linda M. Rubinstein M.A. (Age 57)
    CFO, Principal Financial Officer & Principal Accounting Officer
    Compensation: $940.99k
  • Mr. Kishor Peter Soparkar J.D. (Age 53)
    Chief Operating Officer
    Compensation: $674.98k
  • Dr. Setareh Seyedkazemi Pharm.D. (Age 50)
    Chief Development Officer
    Compensation: $656.84k
  • Dr. R. Andrew Ramelmeier Ph.D. (Age 62)
    Chief Technology Officer
  • Dr. Romuald Corbau Ph.D. (Age 55)
    Chief Scientific Officer
  • Mr. John W. Rakow J.D. (Age 67)
    Senior VP & General Counsel
    Compensation: $954.24k
  • Ms. Dena House
    Chief People Officer
  • Ms. Carla Fiankan
    Senior Vice President of Regulatory Affairs
  • Mr. Michael Steel
    Senior Vice President of Quality


This page (NASDAQ:ADVM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners